These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 6384121)
21. Generation of biologically active, complement-(C5) derived peptides by cathepsin H. Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181 [TBL] [Abstract][Full Text] [Related]
22. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe. Donabedian H; Gallin JI J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618 [TBL] [Abstract][Full Text] [Related]
23. Exposure of human neutrophils to chemotactic factors potentiates activation of the respiratory burst enzyme. Bender JG; McPhail LC; Van Epps DE J Immunol; 1983 May; 130(5):2316-23. PubMed ID: 6300243 [TBL] [Abstract][Full Text] [Related]
24. Neutrophil transepithelial migration in response to the chemoattractant fMLP but not C5a is phospholipase D-dependent and related to the use of CD11b/CD18. Carrigan SO; Pink DB; Stadnyk AW J Leukoc Biol; 2007 Dec; 82(6):1575-84. PubMed ID: 17724165 [TBL] [Abstract][Full Text] [Related]
25. Stimulus-specific effects of endotoxin on superoxide production by rabbit polymorphonuclear leukocytes. Rosenbaum JT; Enkel H Yale J Biol Med; 1987; 60(5):391-6. PubMed ID: 2827396 [TBL] [Abstract][Full Text] [Related]
26. The role of endogenous eicosanoids in rabbit-intraocular inflammation. Kulkarni PS J Ocul Pharmacol; 1991; 7(3):227-41. PubMed ID: 1664445 [TBL] [Abstract][Full Text] [Related]
27. Neutrophil dysfunction in sepsis. II. Evidence for the role of complement activation products in cellular deactivation. Solomkin JS; Jenkins MK; Nelson RD; Chenoweth D; Simmons RL Surgery; 1981 Aug; 90(2):319-27. PubMed ID: 7256544 [TBL] [Abstract][Full Text] [Related]
28. Differential neutrophil activation before and after endotoxin infusion in enterally versus parenterally fed volunteers. Meyer J; Yurt RW; Duhaney R; Hesse DG; Tracey KJ; Fong Y; Richardson D; Calvano S; Dineen P; Shires GT Surg Gynecol Obstet; 1988 Dec; 167(6):501-9. PubMed ID: 2847338 [TBL] [Abstract][Full Text] [Related]
29. C5a receptor modulation on neutrophils and monocytes from chronic hemodialysis and peritoneal dialysis patients. Lewis SL; Van Epps DE; Chenoweth DE Clin Nephrol; 1986 Jul; 26(1):37-44. PubMed ID: 3488153 [TBL] [Abstract][Full Text] [Related]
30. Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts. Senior RM; Griffin GL; Perez HD; Webster RO J Immunol; 1988 Nov; 141(10):3570-4. PubMed ID: 3183381 [TBL] [Abstract][Full Text] [Related]
31. Antigenic identification of chemotactic factor inactivator in normal human serum and bronchoalveolar lavage fluid. Robbins RA; Rasmussen JK; Clayton ME; Gossman GL; Kendall TJ; Rennard SI J Lab Clin Med; 1987 Sep; 110(3):292-9. PubMed ID: 3611952 [TBL] [Abstract][Full Text] [Related]
32. Chemotaxis, spreanding nd oxidative metabolism of neutrophils: influence of albumin in vitro. Valerius NH Acta Pathol Microbiol Immunol Scand C; 1983 Feb; 91(1):43-9. PubMed ID: 6306991 [TBL] [Abstract][Full Text] [Related]
33. Intravascular IL-8. Inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. Hechtman DH; Cybulsky MI; Fuchs HJ; Baker JB; Gimbrone MA J Immunol; 1991 Aug; 147(3):883-92. PubMed ID: 1650387 [TBL] [Abstract][Full Text] [Related]
34. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity. Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828 [TBL] [Abstract][Full Text] [Related]
35. Irreversible neutrophil aggregation. A mechanism of decreased newborn neutrophil chemotactic response. Mease AD; Burgess DP; Thomas PJ Am J Pathol; 1981 Jul; 104(1):98-102. PubMed ID: 7258298 [TBL] [Abstract][Full Text] [Related]
36. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. Senior RM; Skogen WF; Griffin GL; Wilner GD J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361 [TBL] [Abstract][Full Text] [Related]
37. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2. Movat HZ; Rettl C; Burrowes CE; Johnston MG Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579 [TBL] [Abstract][Full Text] [Related]
39. Antiinflammatory effects of endotoxin. Inhibition of rabbit polymorphonuclear leukocyte responses to complement (C5)-derived peptides in vivo and in vitro. Rosenbaum JT; Hartiala KT; Webster RO; Howes EL; Goldstein IM Am J Pathol; 1983 Dec; 113(3):291-9. PubMed ID: 6228151 [TBL] [Abstract][Full Text] [Related]
40. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a des Arg. Marder SR; Chenoweth DE; Goldstein IM; Perez HD J Immunol; 1985 May; 134(5):3325-31. PubMed ID: 3884709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]